Test Code HIAAR 5-Hydroxyindoleacetic Acid, Random, Urine
Ordering Guidance
This test uses a random urine collection to assess 5-hydroxyindoleacetic acid concentrations. If a 24-hour urine collection is preferred, order HIAA / 5-Hydroxyindoleacetic Acid, 24 Hour, Urine.
Necessary Information
Patient's age and sex are required.
Specimen Required
Patient Preparation:
1. Some medications could interfere with test results. The ordering provider should decide if any medications should be stopped and when they should be restarted. If clinically feasible, discontinue the following medications at least 48 hours prior to specimen collection:
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
2. For 48 hours prior to the urine collection, the patient should:
Limit the following to one serving per day:
-Fruits
-Vegetables
-Nuts
-Caffeinated beverages or foods
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Store and send refrigerate
Useful For
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using random urine specimens
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
5-HIAA, Random, USpecimen Type
UrineSpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 56 days | |
Frozen | 365 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Clinical Information
5-Hydroxyindoleacetic acid (5-HIAA) is the major metabolite of serotonin and is excreted in the urine. Intestinal carcinoid tumors, along with neuroendocrine tumors, can produce excess amounts of 5-HIAA and serotonin, especially in individuals with carcinoid syndrome. Carcinoid syndrome is characterized by carcinoid tumors, flushing, heart disease, and hepatomegaly.
Measurement of 5-HIAA in a random urine specimen can diagnose carcinoid disease with a high specificity.
Reference Values
5-HIAA, mg/g creatinine 99th percentile cutoff |
|||
Age |
Female |
Male |
|
≤23 months |
≤17.53 |
≤16.42 |
|
24-35 months |
≤17.07 |
≤15.96 |
|
3 years |
≤16.70 |
≤15.60 |
|
4 years |
≤16.03 |
≤14.93 |
|
5 years |
≤15.26 |
≤14.17 |
|
6 years |
≤14.40 |
≤13.34 |
|
7 years |
≤13.47 |
≤12.43 |
|
8 years |
≤12.52 |
≤11.52 |
|
9 years |
≤11.58 |
≤10.63 |
|
10 years |
≤10.67 |
≤9.79 |
|
11 years |
≤9.81 |
≤9.00 |
|
12 years |
≤9.02 |
≤8.29 |
|
13 years |
≤8.32 |
≤7.65 |
|
14 years |
≤7.70 |
≤7.08 |
|
15 years |
≤7.16 |
≤6.59 |
|
16 years |
≤6.72 |
≤6.15 |
|
17 years |
≤6.36 |
≤5.78 |
|
18 years |
≤6.08 |
≤5.45 |
|
19 years |
≤5.88 |
≤5.17 |
|
20 years |
≤5.73 |
≤4.93 |
|
21 years |
≤5.64 |
≤4.73 |
|
22 years |
≤5.59 |
≤4.55 |
|
23 years |
≤5.57 |
≤4.40 |
|
24 years |
≤5.57 |
≤4.28 |
|
25 years |
≤5.58 |
≤4.19 |
|
26 years |
≤5.61 |
≤4.11 |
|
27 years |
≤5.64 |
≤4.06 |
|
28 years |
≤5.67 |
≤4.03 |
|
29 years |
≤5.70 |
≤4.02 |
|
30 years |
≤5.72 |
≤4.01 |
|
31 years |
≤5.75 |
≤4.02 |
|
32 years |
≤5.77 |
≤4.03 |
|
33 years |
≤5.78 |
≤4.05 |
|
34 years |
≤5.79 |
≤4.06 |
|
35 years |
≤5.80 |
≤4.08 |
|
36 years |
≤5.80 |
≤4.09 |
|
37 years |
≤5.80 |
≤4.11 |
|
38 years |
≤5.80 |
≤4.12 |
|
39 years |
≤5.81 |
≤4.14 |
|
40 years |
≤5.82 |
≤4.17 |
|
41 years |
≤5.85 |
≤4.22 |
|
42 years |
≤5.89 |
≤4.27 |
|
43 years |
≤5.95 |
≤4.35 |
|
44 years |
≤6.04 |
≤4.43 |
|
45 years |
≤6.14 |
≤4.53 |
|
46 years |
≤6.26 |
≤4.63 |
|
47 years |
≤6.40 |
≤4.75 |
|
48 years |
≤6.55 |
≤4.86 |
|
49 years |
≤6.71 |
≤4.99 |
|
50 years |
≤6.86 |
≤5.11 |
|
51 years |
≤7.01 |
≤5.24 |
|
52 years |
≤7.15 |
≤5.37 |
|
53 years |
≤7.29 |
≤5.51 |
|
54 years |
≤7.41 |
≤5.64 |
|
55 years |
≤7.52 |
≤5.78 |
|
56 years |
≤7.62 |
≤5.91 |
|
57 years |
≤7.71 |
≤6.05 |
|
58 years |
≤7.80 |
≤6.17 |
|
59 years |
≤7.88 |
≤6.29 |
|
60 years |
≤7.95 |
≤6.41 |
|
61 years |
≤8.02 |
≤6.51 |
|
62 years |
≤8.09 |
≤6.60 |
|
63 years |
≤8.15 |
≤6.69 |
|
64 years |
≤8.21 |
≤6.76 |
|
65 years |
≤8.28 |
≤6.82 |
|
66 years |
≤8.34 |
≤6.88 |
|
67 years |
≤8.40 |
≤6.93 |
|
68 years |
≤8.46 |
≤6.97 |
|
69 years |
≤8.52 |
≤7.00 |
|
70 years |
≤8.58 |
≤7.03 |
|
71 years |
≤8.65 |
≤7.06 |
|
72 years |
≤8.71 |
≤7.08 |
|
73 years |
≤8.77 |
≤7.10 |
|
74 years |
≤8.82 |
≤7.11 |
|
75 years |
≤8.86 |
≤7.11 |
|
76 years |
≤8.90 |
≤7.11 |
|
77 years |
≤8.92 |
≤7.10 |
|
78 years |
≤8.93 |
≤7.09 |
|
79 years |
≤8.93 |
≤7.07 |
|
80 years |
≤8.92 |
≤7.05 |
|
81 years |
≤8.90 |
≤7.02 |
|
82 years |
≤8.88 |
≤7.00 |
|
83 years |
≤8.86 |
≤6.98 |
|
84 years |
≤8.85 |
≤6.97 |
|
85 years |
≤8.84 |
≤6.95 |
|
86 years |
≤8.84 |
≤6.94 |
|
87 years |
≤8.84 |
≤6.94 |
|
88 years |
≤8.84 |
≤6.94 |
|
>or= 89 years |
≤8.85 |
≤6.93 |
|
Interpretation
If pharmacological and dietary artifacts have been ruled out, an elevated excretion of 5-hydroxyindoleacetic acid is a probable indicator of the presence of a serotonin-producing tumor.
Cautions
Intake of food with a high content of serotonin (avocados, dates, eggplant, all fruit [including bananas, cantaloupe, grapefruit, kiwifruit, melons, pineapple, plantains, plums], all nuts [including hickory nuts, butternuts, pecans, walnuts], and tomatoes and tomato products) within 48 hours of the urine collection could result in falsely elevated 5-hydroxyindoleacetic acid (5-HIAA) excretion.
Numerous drugs affect the excretion of 5-HIAA by different mechanisms, including increased serotonin synthesis, metabolism, and release and inhibition of uptake. The following medications can interfere with 5-HIAA results.
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
Patient should also avoid caffeinated beverages, such as tea and coffee, or caffeinated foods, such as dark chocolate, for 48 hours before and during specimen collection.
Method Description
5-Hydroxyindoleacetic acid (5-HIAA) is measured by solid phase extraction of an aliquot from a random urine collection and liquid chromatography tandem mass spectrometry analysis. 5-HIAA is quantitated using a custom synthesized stable isotope labeled internal standard (d6-5-HIAA) from calibration over a concentration range 0.5 to 150 mg/L.(Kroll CA, Magera MJ, Helgeson JK, et al. A liquid chromatography-tandem mass spectrometry method for the determination of 5-hydroxyindole-3-acetic acid in urine. Clin Chem. 2002;48:2049-2051; Calanchini M, Tadman M, Krogh J, Fabbri A, Grossman A, Shine B. Measurement of urinary 5-HIAA: correlation between spot versus 24-h urine collection. Endocr Connect. 2019;8(8):1082-1088)
Day(s) Performed
Monday through Friday
Report Available
2 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83497
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HIAAR | 5-HIAA, Random, U | 11145-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
616090 | 5-HIAA, Random, U | 11145-0 |